Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)

NCT00081770 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4469

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

BIOLOGICAL: PegIntron (peginterferon alfa-2b; SCH 54031)
BIOLOGICAL: PegIntron (peginterferon alfa-2b; SCH 54031)
DRUG: REBETOL (ribavirin; SCH 18908)
BIOLOGICAL: PEGASYS (peginterferon alfa-2a)
DRUG: COPEGUS (ribavirin)

Sponsor

Merck Sharp & Dohme LLC